X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (471) 471
Publication (75) 75
Book / eBook (45) 45
Book Review (11) 11
Patent (6) 6
Dissertation (5) 5
Magazine Article (3) 3
Book Chapter (2) 2
Newspaper Article (2) 2
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (275) 275
female (240) 240
oncology (188) 188
breast neoplasms - drug therapy (136) 136
breast cancer (132) 132
index medicus (115) 115
chemotherapy (108) 108
middle aged (107) 107
adult (95) 95
chemotherapy, adjuvant (84) 84
disease-free survival (77) 77
therapy (77) 77
aged (74) 74
treatment outcome (73) 73
breast neoplasms - pathology (71) 71
antineoplastic combined chemotherapy protocols - therapeutic use (68) 68
cancer (61) 61
clinical trials (61) 61
tamoxifen (59) 59
male (58) 58
prognosis (57) 57
medicine, general & internal (55) 55
breast neoplasms - mortality (49) 49
antineoplastic agents, hormonal - therapeutic use (47) 47
tamoxifen - therapeutic use (46) 46
quality of life (43) 43
child (42) 42
follow-up studies (42) 42
article (41) 41
survival analysis (41) 41
care and treatment (40) 40
survival (40) 40
postmenopausal women (38) 38
risk factors (38) 38
women (38) 38
breast neoplasms - surgery (37) 37
research (37) 37
drug therapy (36) 36
adolescent (34) 34
child, preschool (34) 34
antineoplastic agents - therapeutic use (33) 33
lymphatic metastasis (33) 33
trastuzumab (32) 32
adjuvant treatment (31) 31
survival rate (31) 31
randomized controlled trials as topic (30) 30
analysis (29) 29
health aspects (29) 29
surgery (29) 29
adjuvant chemotherapy (28) 28
endocrine therapy (28) 28
proportional hazards models (28) 28
breast neoplasms - therapy (27) 27
estrogen (27) 27
combined modality therapy (26) 26
infant (26) 26
premenopause (26) 26
breast neoplasms - metabolism (25) 25
cancer therapies (25) 25
drug administration schedule (25) 25
methotrexate - administration & dosage (25) 25
patients (25) 25
postmenopause (25) 25
recurrence (25) 25
tamoxifen - administration & dosage (25) 25
clinical-trials (23) 23
cyclophosphamide - administration & dosage (23) 23
fluorouracil - administration & dosage (23) 23
medical research (23) 23
methotrexate (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
cyclophosphamide (22) 22
randomized-trial (22) 22
tumors (22) 22
antineoplastic agents, hormonal - adverse effects (21) 21
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (21) 21
adjuvant therapy (20) 20
antineoplastic agents - adverse effects (20) 20
hematology, oncology and palliative medicine (20) 20
mastectomy (20) 20
neoplasm staging (20) 20
nitriles - therapeutic use (20) 20
pregnancy (20) 20
risk (20) 20
triazoles - therapeutic use (20) 20
aged, 80 and over (19) 19
breast neoplasms - chemistry (19) 19
breast-cancer (19) 19
clinical trials as topic (19) 19
double-blind method (19) 19
menopause (19) 19
receptors, estrogen - analysis (19) 19
retrospective studies (19) 19
time factors (19) 19
kaplan-meier estimate (18) 18
medicine & public health (18) 18
tamoxifen - adverse effects (18) 18
cancer and oncology (17) 17
cancer och onkologi (17) 17
children (17) 17
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (28) 28
UTL at Downsview - May be requested (16) 16
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (4) 4
Trinity College (John W Graham) - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Regis College - Stacks (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
St. Augustine's Seminary - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10075, pp. 1195 - 1205
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9897, pp. 1021 - 1028
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 4, pp. 297 - 305
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | ERBB2 | INHIBITOR | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Medical research | Ligands | Cytotoxicity | Mammography | Kinases | Cancer therapies | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Surgery | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | Diarrhea | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1137 - 1146
Journal Article
NPJ breast cancer, ISSN 2374-4677, 2019, Volume 5, Issue 1, pp. 1 - 4
Journal Article
Clinical Trials, ISSN 1740-7745, 4/2015, Volume 12, Issue 2, pp. 183 - 184
  Marvin Zelen, a giant in the evolution of clinical trials, died of cancer on 15 November 2014. He was 87 years old. Professor Zelen was the Lemuel Shattuck... 
MEDICINE, RESEARCH & EXPERIMENTAL | Neoplasms - therapy | Clinical Trials as Topic | Statistics as Topic | Research Design | Humans | Clinical trials | College professors | Deaths
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9555, pp. 29 - 36
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 156 - 163
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1101 - 1108
Journal Article